Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03613714 · ClinicalTrials.gov registry record · NA

Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy

A NA study of Hypertension in Pregnancy and Hypertension, Pregnancy Induced, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03613714: Completed NA study of Hypertension in Pregnancy and Hypertension, Pregnancy Induced, sponsored by University of North Carolina, Chapel Hill.

NCT03613714 is a NA study of Hypertension in Pregnancy and Hypertension, Pregnancy Induced that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants, below the 441-participant average among 13 other Hypertension in Pregnancy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03613714, a NA study of Hypertension in Pregnancy and Hypertension, Pregnancy Induced, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Hypertensive disorders of pregnancy (HDP) affect up to 10% of mother-infant dyads and account for 7.4% of cases of maternal mortality in the United States. Prompt recognition and treatment of hypertension remain one of the key features of management of mothers affected by these conditions. Up to 41% of severe morbidity and mortality from HDP occurs after 48 hours postpartum, as postpartum blood pressures tend to peak 3-6 days after birth. For these reasons, early postpartum follow-up is recommended for women diagnosed with HDP, in the form of blood pressure (BP) evaluation by a health care provider at 7-10 days postpartum (2-5 days post-discharge from maternity care). However, barriers to follow-up limit mothers' ability to adhere to this recommendation. A potential alternative to in-office evaluation is at-home BP monitoring. At-home BP monitoring is a novel, affordable method to empower, educate, and engage postpartum women affected by HDP. Within the obstetric (OB) population, pilot studies have demonstrated the feasibility and acceptability of remote BP monitoring. Hence, the purpose of this randomized trial is to empower postpartum women affected by HDP and cared for at North Carolina Women's Hospital to perform at-home BP monitoring with the aid of digital technology.

Primary Outcome

BP evaluation will be counted if performed by clinic staff via telephone or in person if documented in the medical record.

Interventions

  • OTHER At-home Blood Pressure Monitoring

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-09-01
Est. Completion 2019-12-31
Phase NA

What the finished NCT03613714 record still lists

NCT03613714 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 441-participant average among 13 other Hypertension in Pregnancy trials with a reported enrollment target (77% lower).

The record links to 4 conditions, with Hypertension in Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which At-home Blood Pressure Monitoring is the first listed.

NCT03613714 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03613714 about?

NCT03613714 is a clinical study titled "Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy". Hypertensive disorders of pregnancy (HDP) affect up to 10% of mother-infant dyads and account for 7.4% of cases of maternal mortality in the United States. Prompt recognition and treatment of hypertension remain one of the key features of management of mothers affected by these conditions. Up to 41%...

What is the current status of trial NCT03613714?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-09-01. Estimated completion is 2019-12-31.

What conditions does trial NCT03613714 study?

This clinical trial studies the following conditions: Hypertension in Pregnancy, Hypertension, Pregnancy Induced, Blood Pressure Disorders, Postpartum Preeclampsia.

What interventions are being tested in trial NCT03613714?

The interventions under investigation include: At-home Blood Pressure Monitoring (OTHER).

Who is sponsoring clinical trial NCT03613714?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03613714 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension in Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03613714's enrollment target sits among peer trials

100 11th of 13 higher than 2 of 13 other Hypertension in Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension in Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03613714, the US trial registry maintained by the National Library of Medicine. NCT03613714 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.